Clinical Trial Update: PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial evaluating PEG-rhG-CSF in breast cancer patients receiving chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED